insights_auto
Why is NOVO-B up 2.93%?
Dive Deeperchevron_right
NOVO-B:CPH
Novo Nordisk A/S
DKK 263.45
arrow_upward
+2.93%(+7.50) 1D
Oct 15, 5:00:00 PM GMT+2 · DKK
search
All symbols
| Symbol | Price | Change | % Change |
|---|
insights_autoGenerating top insights for NOVO-B...
Open
DKK 255.50
High
DKK 263.45
Low
DKK 254.25
Mkt. cap
870.08B
Avg. vol.
5.18M
Volume
0.00
52-wk high
DKK 409.95
52-wk low
DKK 224.25
Shares outstanding
3.39B
No. of employees
67K
Open
DKK 255.50
High
DKK 263.45
Low
DKK 254.25
Mkt. cap
870.08B
Avg. vol.
5.18M
Volume
0.00
52-wk high
DKK 409.95
52-wk low
DKK 224.25
Shares outstanding
3.39B
No. of employees
67K
News stories
From web sources and news partners
TradingKey
·
7 hours ago
Novo Nordisk A/S Stock (NVO) Moved Up by 3.38% on Oct 15: What Investors Need To Know
Traders Union
·
11 hours ago
Why is Novo Nordisk stock up 3.2% today?
ad-hoc-news.de
·
17 hours ago
Novo Nordisk stock gains 1.12 percent ahead of November 4 results
Traders Union
·
17 hours ago
Novo Nordisk stock consolidates amid seller pressure near $38.39 resistance
Profile
Novo Nordisk A/S, doing business as Novo, is a Danish multinational pharmaceutical company. Novo manufactures and markets pharmaceutical products and services, primarily diabetes and obesity medications and devices. The corporation was created in 1989, through a merger of two Danish pharmaceutical companies, which date back to the 1920s.
Novo employs approximately 68,800 people in 80 countries, and markets its products in approximately 170 countries. Novo is controlled by majority shareholder Novo Holdings which holds 28% of its shares and a majority of its voting shares.
Novo is a full member of the European Federation of Pharmaceutical Industries and Associations.
The company was ranked 25th among Fortune's 100 Best Companies to Work For in 2010, and subsequently ranked 72nd in 2014 and 73rd in 2017. In January 2012, Novo was named the most sustainable company in the world by the business magazine Corporate Knights. It is a leader in the FTSE4Good Index, and the only European company in the top ten.
Novo is the largest pharmaceutical company in Denmark. In 2023, Novo's market capitalization exceeded the GDP of Denmark, and it became the highest valued company in Europe. Wikipedia
About Novo Nordisk A/S
CEOMaziar Mike Doustdar
Employees66.7K
Founded1923
HeadquartersBagsværd, Capital Region of Denmark, Denmark
SectorPharmaceutical industry
Websitenovonordisk.com